The intricate role of CCL5/CCR5 axis in Alzheimer disease

J Neuropathol Exp Neurol. 2023 Oct 20;82(11):894-900. doi: 10.1093/jnen/nlad071.

Abstract

The morbidity and mortality associated with Alzheimer disease (AD), one of the most common neurodegenerative diseases, are increasing each year. Although both amyloid β and tau proteins are known to be involved in AD pathology, their detailed functions in the pathogenesis of the disease are not fully understood. There is increasing evidence that neuroinflammation contributes to the development and progression of AD, with astrocytes, microglia, and the cytokines and chemokines they secrete acting coordinately in these processes. Signaling involving chemokine (C-C motif) ligand 5 (CCL5) and its main receptor C-C chemokine receptor 5 (CCR5) plays an important role in normal physiologic processes as well as pathologic conditions such as neurodegeneration. In recent years, many studies have shown that the CCL5/CCR5 axis plays a major effect in the pathogenesis of AD, but there are also a few studies that contradict this. In short, the role of CCL5/CCR5 axis in the pathogenesis of AD is still intricate. This review summarizes the structure, distribution, physiologic functions of the CCL5/CCR5 axis, and the progress in understanding its involvement in the pathogenesis of AD.

Keywords: Alzheimer disease; Axis; CCL5; CCR5; Neuroinflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides
  • Chemokine CCL5* / metabolism
  • Chemokines
  • Humans
  • Receptors, CCR5 / metabolism
  • Receptors, Chemokine / metabolism

Substances

  • Amyloid beta-Peptides
  • CCL5 protein, human
  • CCR5 protein, human
  • Chemokine CCL5
  • Chemokines
  • Receptors, CCR5
  • Receptors, Chemokine